Results 41 to 50 of about 3,714 (189)

Patients' perspective on their drug therapy after bariatric surgery: A quantitative, cross‐sectional interview study

Clinical Obesity, Volume 14, Issue 5, October 2024.
Graphical abstract on the background, methods, summarized results and conclusion of the study. Summary Drug therapy in patients who have undergone bariatric surgery is challenging. We aimed to investigate the patients' perspective on their drug therapy.
Susanne Schiek, Melissa Drotleff, Dorit Schueler, Katrin Heinitz, Annett Frisch, Lars Selig, Yvonne Remane, Arne Dietrich, Matthias Blüher, Thilo Bertsche   +9 more
wiley   +1 more source

Pramipexole protective effect on rotenone induced neurotoxicity in mice [PDF]

, 2011
Introduction: Pramipexole is a new dopaminergic drug which has been approved for PD treatment. However, we tried to find a new capacity for this drug rather than symptomatic effect. Materials and Methods: A chronic
Abdelaziz A. Ghanem, Dina El-Tantawy, Hasan Abd-Elghaffar, Mohamed M. Salama, Sahar A. El-Dakroury, Sara El-Dosouky, Seham A. Gad-Elhak   +6 more
core   +1 more source

Prevalence of Late‐Stage Parkinson's Disease in the US Healthcare System: Insights from TriNetX

Movement Disorders, Volume 39, Issue 9, Page 1592-1601, September 2024.
Abstract Background Patients in late‐stage Parkinson's disease (PDLS) are caregiver‐dependent, have low quality of life, and higher healthcare costs. Objective To estimate the prevalence of PDLS patients in the current US healthcare system. Methods We downloaded the 2010–2022 data from the TriNetX Diamond claims network that consists of 92 US ...
Sol De Jesus, Annika Daya, Liba Blumberger, Mechelle M. Lewis, Doug Leslie, Samer D. Tabbal, Rachel Dokholyan, Amanda M. Snyder, Richard B. Mailman, Xuemei Huang   +9 more
wiley   +1 more source

Defining the Role of Trimetazidine in the Treatment of Cardiovascular Disorders: Some Insights on Its Role in Heart Failure and Peripheral Artery Disease [PDF]

, 2014
Trimetazidine is a cytoprotective drug whose cardiovascular effectiveness, especially in patients with stable ischemic heart disease, has been the source of much controversy in recent years; some have gone so far as to treat the medication as a ‘placebo ...
Jacek Rysz, Maciej Banach, Piotr Chrusciel   +2 more
core   +1 more source

Heterogeneous treatment effects of sodium‐glucose cotransporter 2 inhibitors on risk of dementia in people with type 2 diabetes: A population‐based cohort study

Alzheimer's &Dementia, Volume 20, Issue 8, Page 5528-5539, August 2024.
Abstract INTRODUCTION Sodium‐glucose cotransporter 2 (SGLT2) inhibitors exhibit potential benefits in reducing dementia risk, yet the optimal beneficiary subgroups remain uncertain. METHODS Individuals with type 2 diabetes (T2D) initiating either SGLT2 inhibitor or sulfonylurea were identified from OneFlorida+ Clinical Research Network (2016–2022).
Huilin Tang, William T. Donahoo, Mikael Svensson, C. Elizabeth Shaaban, Glenn Smith, Michael S. Jaffee, Yu Huang, Xia Hu, Ying Lu, Ramzi G. Salloum, Steven T. DeKosky, Jiang Bian, Jingchuan Guo   +12 more
wiley   +1 more source

In Vivo Studies of various Antiparkinson’s agents: A Systematic Review

International Journal for Research in Applied Science and Engineering Technology, 2022
Abstract: Parkinson’s disease (PD) is a neurodegenerative disorder which is characterized by typical symptoms including gradual progressive muscle rigidity, tremor and loss of motor skills. Although there is no definitive cure for PD, the extract of some medicinal plants and their ingredients have been suggested to relieve its symptoms and to prevent ...
Nimisha Vasava, Vipul Gajera
openaire   +1 more source

The effect of cabergoline on level of liver enzymes [PDF]

, 2011
زمینه و هدف: به علت اهمیت نقش کبد در ارتباط با متابولیسم داروهای شیمیایی و سنتز پروتئین های پلاسما و استفاده زیاد از داروی کابرگولین در درمان بیماری هیپرپرولاکتینمیا، پارکینسون و برخی اختلالات دیگر این مطالعه با هدف بررسی اثر داروی کابرگولین بر غلظت ...
Azarnoush, Jaleh., Mokhtari, Mokhtar., Shariatie, Mehrdad.   +2 more
core  

Dopamine Activation Preserves Visual Motion Perception Despite Noise Interference of Human V5/MT [PDF]

, 2016
Copyright © 2016 Yousif et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution License Creative Commons Attribution 4.0 International, which permits unrestricted use, distribution and reproduction in any ...
Abou-El-Ela Bourquin, Bilal, Bhrugubanda, Vamsee, Fu, Richard, Schultz, Simon R, Seemungal, Barry M, Yousif, Nada   +5 more
core   +3 more sources

Optimal dose for the efficacy of asenapine in patients with schizophrenia: Real‐world data

Neuropsychopharmacology Reports, Volume 44, Issue 1, Page 234-239, March 2024.
A meta‐analysis of large short‐term studies found no significant difference between asenapine doses of 10 and 20 mg/day for acute schizophrenia treatment. However, these studies' homogeneous patient populations may not accurately represent the diversity seen in clinical practice.
Yoshiteru Takekita, Shuichi Hiraoka, Yasuhiro Iwama, Daisuke Matsui, Nobuatsu Aoki, Haruhiko Ogata, Toshiya Funatsuki, Toshiyuki Shimizu, Yuji Murase, Yosuke Koshikawa, Masaki Kato, Toshihiko Kinoshita   +11 more
wiley   +1 more source

Managing Medicaid Pharmacy Benefits: Current Issues and Options [PDF]

, 2011
Examines issues and considerations for state reforms of Medicaid prescription drug reimbursement, pharmacy management, and cost sharing and other best practices for realizing ...
Robin Rudowitz, Sandy Kramer, Vernon K. Smith   +2 more
core